U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270302) titled 'Nebulized Nasal Steroids' on Nov. 25.
Brief Summary: The goal of the proposed project is to assess the efficacy, safety, and patient experience of budesonide administered via the NasoNeb system for medical management of CRS. The authors propose a randomized controlled trial of nebulized budesonide via the NasoNeb compared against budesonide lavage.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Rhinosinusitis
Intervention:
COMBINATION_PRODUCT: nebulized budesonide via NasoNeb
For the nebulization group, each dose will be dissolved in 10 mL saline with 5 mL nebulized solution being applied to each na...